An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants with Relapsed or Refractory Multiple Myeloma
ENROLLING
Trial ID:
NCT05372354 Protocol # :
23-291
Phase
I/II
Disease Sites
Multiple Myeloma
Principal Investigator
Hartley-Brown, Monique
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #23-291
23-291